Table 2 The clinical information of normal controls and patients with COVID-19 pneumonia.
|  | Normal controls (n = 16) | Common patients (n = 34) | Severe patients (n = 14) | Critical patients (n = 6) | P value |
|---|---|---|---|---|---|
Ages (years old) | 55 ± 13 | 50 ± 15 | 63 ± 5 | 75 ± 10 | − |
Gender(male/female) | 6/10 | 14/20 | 6/8 | 2/4 | − |
White blood cell (×109/L) | 6.46 ± 0.36 | 4.02 ± 0.23 | 7.36 ± 0.76 | 8.39 ± 1.38 | 0.000 |
Neutrophil (×109/L) | 3.61 ± 0.25 | 2.47 ± 0.21 | 5.41 ± 0.71 | 7.57 ± 1.26 | 0.000 |
Lymphocyte (×109/L) | 2.36 ± 0.14 | 1.13 ± 0.08 | 1.22 ± 0.24 | 0.41 ± 0.11 | 0.000 |
Monocyte (×109/L) | 0.36 ± 0.02 | 0.25 ± 0.02 | 0.49 ± 0.11 | 0.26 ± 0.06 | 0.005 |
Neutrophil (%) | 55.18 ± 1.63 | 60.07 ± 2.02 | 71.24 ± 4.03 | 89.38 ± 1.99 | 0.000 |
Lymphocyte (%) | 34.86 ± 2.56 | 29.11 ± 1.95 | 17.98 ± 3.07 | 5.54 ± 1.18 | 0.000 |
Monocyte (%) | 5.72 ± 0.47 | 6.37 ± 0.33 | 7.01 ± 1.58 | 3.18 ± 0.47 | 0.082 |
Alanine aminotransferase (U/L) | 19.85 ± 2.33 | 49.53 ± 9.8 | 49.29 ± 9.1 | 49.17 ± 15.06 | 0.232 |
Aspartate aminotransferase (U/L) | 22.23 ± 1.71 | 38.53 ± 5.41 | 39.14 ± 5.79 | 85.17 ± 31.05 | 0.003 |
Total bilirubin (μmol/L) | 14.71 ± 1.29 | 9.73 ± 0.56 | 11.29 ± 2.16 | 18.40 ± 2.24 | 0.000 |
Direct bilirubin (μmol/L) | 4.67 ± 0.47 | 1.91 ± 0.12 | 3.79 ± 1.81 | 6.52 ± 1.58 | 0.006 |
Total protein (g/L) | 74.93 ± 1.02 | 73.52 ± 0.92 | 71.69 ± 2.02 | 69.52 ± 3.64 | 0.241 |
Albumin (g/L) | 46.1 ± 0.54 | 36.70 ± 0.71 | 31.05 ± 0.96 | 30.70 ± 1.88 | 0.000 |
Creatinine (μmol/L) | 56.19 ± 2.92 | 59.94 ± 2.76 | 56.43 ± 3.66 | 96.83 ± 25.72 | 0.002 |
Glomerular filtration rate (mL/min/1.73 m2) | 126.59 ± 5.62 | 113.32 ± 5.62 | 101.19 ± 3.47 | 70.85 ± 14.15 | 0.000 |
Procalcitonin (ng/mL) | 0.10 ± 0.001 | 0.13 ± 0.004 | 0.18 ± 0.04 | 3.42 ± 3.15 | 0.015 |
C reactive protein (mg/L) | 2.50 ± 0.25 | 16.50 ± 2.73 | 46.34 ± 9.82 | 96.73 ± 21.72 | 0.000 |
Saturation of oxygen (%) | 98.53 ± 1.21 | 96.83 ± 0.90 | 92.84 ± 0.59 | 87.03 ± 2.95 | 0.019 |
